HONOLULU (AP) — The U.S. Food and Drug Administration continues to overly restrict access to mifepristone, a medication for abortions and miscarriage management, a lawyer for the American Civil Liberties Union argued Friday in a lawsuit by a Hawaii doctor and healthcare associations challenging the legality of the restrictions.

They are asking a judge to find that the FDA violated the law by restricting a safe medication without scientific justification, but stop short of flat-out seeking an immediate elimination of the restrictions, which currently include special certification for prescribers and pharmacies and requiring patients to review a counseling form.

Plaintiffs are taking the “more modest approach” to give the agency an opportunity to correct its errors, Julia Kaye, senior staf

See Full Page